USPTO serial 87291781
DURASERT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 5, 2019
- Examiner
- TAYLOR, DAVID T
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with DURASERT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Watertown, MA, US
EYEPOINT PHARMACEUTICALS US, INC.
WATERTOWN, MA, US
Watertown, MA, US
EYEPOINT PHARMACEUTICALS US, INC.
WATERTOWN, MA, US
WATERTOWN, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kimberly Jarman, Esq.
Kimberly Jarman, Esq. EyePoint Pharmaceuticals480 Pleasant StreetSuite A210Watertown, MA 02472Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Injectable drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals via injection into the posterior chamber of the eye for the treatment of diseases and conditions, including ocular diseases, namely, uveitis and retinal disease | ACTIVE | May 10, 2019 |
| 010 | Injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior chamber of the eye | ACTIVE | May 10, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by pSivida US, Inc.
- Other trademarks owned by EYEPOINT PHARMACEUTICALS US, INC.
- Other trademarks owned by pSivida US, Inc.
- Other trademarks owned by EYEPOINT PHARMACEUTICALS US, INC.
- Other trademarks owned by EYEPOINT US, INC.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named DURASERT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 31, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 31, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 31, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 26, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 5, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 28, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 28, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 28, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 28, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 30, 2019 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 30, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 18, 2019 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Nov 5, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 1, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 30, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 4, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 27, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 31, 2019 | IUAF | USE AMENDMENT FILED | — |
| Jul 31, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 11, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 7, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 7, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 7, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 15, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 13, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 13, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 13, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 1, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 27, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 27, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 27, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 18, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 23, 2017 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Dec 22, 2017 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 12, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 8, 2017 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Oct 26, 2017 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Oct 17, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 17, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 18, 2017 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Apr 18, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 18, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 29, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 3, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 10, 2017 | NWAP | NEW APPLICATION ENTERED | — |